Conditions: Dermatitis, Atopic; Dermatitis; Eczema; Skin Diseases; Skin Diseases, Genetic; Genetic Diseases, Inborn; Skin Diseases, Eczematous; Hypersensitivity; Hypersensitivity, Immediate; Immune System Diseases
Interventions: Drug: Benralizumab; Drug: Placebo Control
Sponsors: McMaster University; AstraZeneca
Not yet recruiting
https://ift.tt/2MtALTB
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου